Avi Mazaltov
Corporate Officer/Principal chez VBI VACCINES INC.
Fortune : 2 251 $ au 31/03/2024
Profil
Avi Mazaltov is currently the General Manager at SciVac Ltd.
and the Global Head-Manufacturing at VBI Vaccines, Inc. He previously worked as the Director-Global Manufacturing & Plant Manager at Teva Pharmaceuticals USA, Inc. from 1993 to 2002 and as the President-Operations at Alvarion Ltd.
from 2002 to 2010.
Mr. Mazaltov received his undergraduate degree from Ben-Gurion University of the Negev in 1989.
Détentions connues dans des sociétés publiques
Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
---|---|---|---|---|
VBI VACCINES, INC.
0,02% | 27/07/2023 | 3 733 ( 0,02% ) | 2 251 $ | 31/03/2024 |
Postes actifs de Avi Mazaltov
Sociétés | Poste | Début |
---|---|---|
VBI VACCINES INC. | Corporate Officer/Principal | 30/03/2017 |
SciVac Ltd.
SciVac Ltd. BiotechnologyHealth Technology Part of VBI Vaccines, Inc., SciVac Ltd. is an Israeli company that develops and markets biological products for human healthcare. The private company is based in Rehovot, Israel. SciVac was acquired by Levon Resources Ltd. on July 09, 2015 for $73.16 million. | Corporate Officer/Principal | - |
Anciens postes connus de Avi Mazaltov
Sociétés | Poste | Fin |
---|---|---|
Teva Pharmaceuticals USA, Inc.
Teva Pharmaceuticals USA, Inc. Pharmaceuticals: MajorHealth Technology Teva Pharmaceuticals USA, Inc. engages in the manufacturing and marketing of generic pharmaceuticals. The firm also provides medical affairs, quality plus safety and trade partner services. The company was founded in 1985 and is headquartered in Parsippany, NJ. | Corporate Officer/Principal | 01/04/2002 |
ALVARION LTD. | Corporate Officer/Principal | - |
Formation de Avi Mazaltov
Ben-Gurion University of the Negev | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 2 |
---|---|
ALVARION LTD. | Electronic Technology |
VBI VACCINES INC. | Health Technology |
Entreprise privées | 2 |
---|---|
Teva Pharmaceuticals USA, Inc.
Teva Pharmaceuticals USA, Inc. Pharmaceuticals: MajorHealth Technology Teva Pharmaceuticals USA, Inc. engages in the manufacturing and marketing of generic pharmaceuticals. The firm also provides medical affairs, quality plus safety and trade partner services. The company was founded in 1985 and is headquartered in Parsippany, NJ. | Health Technology |
SciVac Ltd.
SciVac Ltd. BiotechnologyHealth Technology Part of VBI Vaccines, Inc., SciVac Ltd. is an Israeli company that develops and markets biological products for human healthcare. The private company is based in Rehovot, Israel. SciVac was acquired by Levon Resources Ltd. on July 09, 2015 for $73.16 million. | Health Technology |